Columvi 50242-0125

Generic: Glofitamab

Product NDC

50242-0125

Manufacturer: Genentech, Inc.
Dosage Form: Solution, Concentrate
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: June 15, 2023
Listing Expires: December 31, 2026
Application: BLA761309

Need to source Columvi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Glofitamab	2.5 mg/2.5mL

Drug Class

Bispecific CD20-directed CD3 T Cell Engager [EPC]Bispecific CD20-directed CD3 T Cell Engager [EPC]CD20-directed Antibody Interactions [MoA]

Packaging Options(1)

50242-0125-01

1 VIAL, SINGLE-DOSE in 1 CARTON (50242-125-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE

View →